Experience

Olive Diagnostics

• Israel
• Medical Equipment Manufacturing
• 1 - 100 Employee

• EVP of R&D and Engineering.

  • Jan 2022 - Present

  Israel



JLM-BioCity

• Israel
• Biotechnology Research
• 1 - 100 Employee

• Executive Advisor to CEO & Board member

  • Jan 2020 - Present

  Jerusalem, Israel



SolAround

• Israel
• Renewable Energy Semiconductor Manufacturing
• 1 - 100 Employee

• VP Business Development

  • Feb 2018 - Oct 2020

  Israel SolAround develops best-in-class high power, high efficiency bifacial p-Si PERT solar cells and modules, significantly reducing LCOE and doubling IRR in solar projects. SolAround's cell has 23% front efficiency, 0.95 bifaciality, and 27% to 30% bifacial equivalent efficiency per application, in a standard market cost. SolAround's 60 cell bifacial modules shall have a front power of 320Wp and a total bifacial power of up to 430Wp-equivalent per installation conditions. SolAround’s… Show more SolAround develops best-in-class high power, high efficiency bifacial p-Si PERT solar cells and modules, significantly reducing LCOE and doubling IRR in solar projects. SolAround's cell has 23% front efficiency, 0.95 bifaciality, and 27% to 30% bifacial equivalent efficiency per application, in a standard market cost. SolAround's 60 cell bifacial modules shall have a front power of 320Wp and a total bifacial power of up to 430Wp-equivalent per installation conditions. SolAround’s products provide higher yields in harsh environments such as cloudy and foggy weather patterns, snow, and dusty desert conditions, in addition to grid balancing. The company’s bifacial cells and modules are ideal for white flat rooftops (eligible for significant US tax credits), utility ground installations, vertical east-west installations, sound barriers, green buildings and for various forms of BIPV. Show less



OneCell Medical LTD

• Israel
• Biotechnology Research
• 1 - 100 Employee

• Chief Executive Officer

  • Nov 2019 - Jul 2020

  Raanana, Israel

• CEO & Co-Founder

  • Feb 2015 - Oct 2019

  Jerusalem, Israel JLM-BioCity is a non-profit organization set to develop, support and promote the biomedical community of Jerusalem. In addition to creating a platform for companies, academics and biotech professionals to interact, we bring together start-ups and established companies as well as VCs and private investors. JLM-BioCity is also developing various projects aimed to further support new companies in various aspects including bizDev, HR, finances and more.



Azrieli College of Engineering Jerusalem עזריאלי מכללה אקדמית להנדסה ירושלים

• Israel
• Higher Education
• 100 - 200 Employee

• External Lecturer, Introduction to Biotechnology

  • Oct 2017 - Jun 2019

  Jerusalem Area, Israel Introduction to Biotechnology is meant to open a window to the industry world by meeting with the leading executives in the various sub-sectors of the Bio world stretching from the Academic research to the basics of finance and investments. The meetings are student friendly, providing a convenient and welcoming environment for open knowledge exchange.



Global Close Alliances (GCA)

• Outsourcing and Offshoring Consulting

• Affiliated Partner

  • Apr 2017 - May 2019

  Israel , Global The GlobalClose Alliances™ Group (GCA ) is a global management consulting, technology services and outsourcing company, with offices in 19 countries and clients and contacts in more than 54 countries. Through its global offices and network of affiliated partners, GCA provides strategic and operational business consulting to government and corporate clients. GCA collaborates with its clients, helping them to become high-performance businesses and governments. GCA’s Senior Partners are… Show more The GlobalClose Alliances™ Group (GCA ) is a global management consulting, technology services and outsourcing company, with offices in 19 countries and clients and contacts in more than 54 countries. Through its global offices and network of affiliated partners, GCA provides strategic and operational business consulting to government and corporate clients. GCA collaborates with its clients, helping them to become high-performance businesses and governments. GCA’s Senior Partners are industry leaders with unparalleled experience, and solid records of success in a variety of industries including: Life Sciences, Health Care, Biotechnology, Real Estate, Venture Capital, Finance and Investment Banking, Academic Management &Technology Transfer. GCA partners come from some of the world’s most successful global companies and academic institutions. Professionalism, experience and strategic understanding are the bedrock of a solid GCA partnership. Show less



Molecular Detection Israel

• Chief Scientific Officer

  • Mar 2015 - Oct 2016

  Jerusalem, Israel Molecular Detection is a medical device diagnostic company developing an automated molecular based diagnostic platform for microbial infections. Our innovative technology enables the rapid and specific detection of microbial blood infections, with additional pipeline applications spanning a variety of infectious diseases. As the Chief Scientific Officer, I lead the R&D, engineering, production and overall design of our automated instrument. The team managed to solve the main problem in sepsis… Show more Molecular Detection is a medical device diagnostic company developing an automated molecular based diagnostic platform for microbial infections. Our innovative technology enables the rapid and specific detection of microbial blood infections, with additional pipeline applications spanning a variety of infectious diseases. As the Chief Scientific Officer, I lead the R&D, engineering, production and overall design of our automated instrument. The team managed to solve the main problem in sepsis diagnosis - isolating, concentrating and cleaning the pathogens from the blood, making the sample suitable for molecular testing such as qRT-PCR. Show less



Life Sciences Israel conference, Tel Aviv

• Academic Promoter

  • Oct 2013 - Mar 2015

  Tel-Aviv, Israel Actively contributed in creating a novel domain for inexperienced PhD students. Advised to the conference organizers during the construction of the program for academics and played a key role in planning the networking platform for the students and companies.



Hadassah Ein-Kerem Hospital and The Hebrew University Medical School

• Post doctoral fellowship

  • Jan 2011 - Mar 2015

  Hadassah Ein-Kerem Hospital and The Hebrew University Medical School My research was conducted in the labs of Prof. Ben Glaser (Hadassah Medical Center, Endocrinology Dept) and Prof. Yuval Dor (The Hebrew University). My research focused on developmental biology (new hormone producing cell in the pancreas) and applicable cancer research (new drug for the prevention and treatment of pancreatic neuro-endocrine tumors). A third project with therapeutic application was aimed at type 1 diabetes (in vivo induction of adult human beta cells regeneration for… Show more My research was conducted in the labs of Prof. Ben Glaser (Hadassah Medical Center, Endocrinology Dept) and Prof. Yuval Dor (The Hebrew University). My research focused on developmental biology (new hormone producing cell in the pancreas) and applicable cancer research (new drug for the prevention and treatment of pancreatic neuro-endocrine tumors). A third project with therapeutic application was aimed at type 1 diabetes (in vivo induction of adult human beta cells regeneration for transplantation in type1 diabetes patients). Show less



NextGen Biomed Ltd

• Director Of Operations And Business Development

  • Jun 2014 - Jan 2015

  Tel Aviv Area, Israel Nextgen-Biomed is a pharmaceutical company holding 98.6% of Dermipsor which develops topical treatment for Psoriasis. Dermipsor was founded in 2004 based on the invention of Dr. Avikam Harel, head of pediatric dermatology at Ichilov Hospital.



TenCure LTD.

• Head of R&D

  • Sep 2013 - Jul 2014

  Jerusalem, Israel Leading the R&D activity in the companyand the preparations for clinical trials



Hadassa Medical center The Hebrew University Jerusalem

• Israel
• Biotechnology
• 700 & Above Employee

• PhD

  • Sep 2005 - Sep 2010

  Hadassah Ein Kerem, Jerusalem Study of how globally developmental signaling pathways act to eliminate damaged or potentially dangerous cells in developing tissues; understanding the mechanisms utilized to enable identical organ development despite genetic sexual differences •Key role in helping establish and develop new lab following its opening •Lab management including human resources, research project management •Presentation of laboratory's research and findings at local and international conferences


Israel Aircraft Industry; Security Department
• Shift leader

  • Jan 2001 - May 2002


Israel Defense Forces

• Israel
• Armed Forces
• 700 & Above Employee

• Company comander

  • Feb 1998 - Dec 1999

  Israel Company commander in the Armored Forces.